Joint symposium on diabetes will be held at NIH May 13-14

Joint symposium on diabetes will be held at NIH May 13-14

The National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) and the Food and Drug Administration (FDA) will co-sponsor a national symposium on diabetes, "Targeting Safe and Effective Prevention and Treatment," May 13-14 on the campus of the National Institutes of Health in Bethesda, MD. The aims of the joint symposium are to define the current state of the prevention, treatment and management of this widespread chronic disease, and identify and discuss therapeutic gaps and hurdles that impede the safe and effective prevention and treatment of type 1 and type 2 diabetes. The meeting is part of NIDDK's current initiative, "From Bench to Bedside, Research on Type 1 Diabetes and Its Complications," and the FDA's initiative to encourage development of therapeutic approaches in areas such s diabetes, lupus, and cancer.

For more information and registration procedures, please visit the FDA/NIH joint symposium website at www.niddk.nih.gov/fund/other/FDA-NIH/index.htm.